| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | Feb 09, 2024 | Sale | $125.50 | 14,702 | 1,845,083 | 46,242 | Feb 12, 2024, 04:03 PM | |
| MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | Feb 09, 2024 | Option Exercise | $62.07 | 14,702 | 912,553 | 60,944 | Feb 12, 2024, 04:03 PM | |
| MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | Jan 22, 2024 | Option Exercise | $119.43 | 25,760 | 3,076,517 | 46,242 | Jan 24, 2024, 04:10 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Jan 09, 2024 | Sale | $13.66 | 29,000 | 396,214 | 421,962 | Jan 11, 2024, 06:51 PM | |
| MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | May 01, 2023 | Option Exercise | $115.47 | 524 | 60,506 | 20,471 | May 03, 2023, 04:10 PM | |
| MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | May 01, 2023 | Option Exercise | $115.47 | 1,062 | 122,629 | 20,995 | May 03, 2023, 04:10 PM | |
| MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | Jan 23, 2023 | Option Exercise | $109.88 | 3,275 | 359,857 | 19,933 | Jan 25, 2023, 04:59 PM | |
| MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | May 03, 2022 | Option Exercise | $87.65 | 381 | 33,395 | 16,458 | May 04, 2022, 05:50 PM | |
| MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | May 03, 2022 | Option Exercise | $87.65 | 773 | 67,753 | 16,839 | May 04, 2022, 05:50 PM | |
| MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | May 01, 2022 | Option Exercise | $88.69 | 523 | 46,385 | 16,066 | May 03, 2022, 04:21 PM | |
| MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | May 01, 2022 | Option Exercise | $88.69 | 1,061 | 94,100 | 16,589 | May 03, 2022, 04:21 PM | |
| MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | Feb 24, 2022 | Option Exercise | $73.51 | 3,023 | 222,221 | 15,462 | Feb 28, 2022, 04:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Dec 07, 2021 | Sale | $20.48 | 15,900 | 325,630 | 1,316,000 | Dec 09, 2021, 09:21 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Nov 17, 2021 | Sale | $20.04 | 5,626 | 112,736 | 1,344,374 | Dec 09, 2021, 09:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Nov 19, 2021 | Sale | $20.20 | 13,474 | 272,226 | 1,330,900 | Dec 09, 2021, 09:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Nov 17, 2021 | Sale | $20.04 | 5,626 | 112,736 | 591,637 | Nov 19, 2021, 05:40 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Nov 19, 2021 | Sale | $20.20 | 13,474 | 272,226 | 578,163 | Nov 19, 2021, 05:40 PM | |
| MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | May 04, 2021 | Option Exercise | $75.98 | 238 | 18,083 | 12,310 | May 06, 2021, 04:55 PM | |
| MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | May 04, 2021 | Option Exercise | $75.98 | 694 | 52,730 | 12,548 | May 06, 2021, 04:55 PM | |
| MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | Feb 26, 2021 | Option Exercise | $72.62 | 3,485 | 253,081 | 10,655 | Mar 02, 2021, 12:00 PM |
Menu